Back

Estimating the penetrance of genetic variants linked to cardiomyopathy

21 May 2022 (16:21 - 16:30)
Organised by:
Congress Presentation Part of: Highlight on cardiomyopathy Clinical HFA Premium Access Heart Failure 2022

About the speaker

Photo
Mr Remco De Brouwer

University Medical Centre Groningen, Groningen (Netherlands (The))

5 More presentations in this session

Presentation thumbnail
Clinical characterization and natural history of chemotherapy-induced dilated cardiomyopathy
Doctor A. Lalario (Trieste, IT)
Abstract Slides Video
Presentation thumbnail
Prognostic implication of neutrophil-lymphocyte ratio (NLR) in myocarditis: results from a multicentre, multinational study.
Doctor A. Cannata (London, GB)
Abstract Slides Video
Presentation thumbnail
Exercise oxygen kinetic in hypertrophic cardiomyopathy: results from a multicenter cardiopulmonary exercise testing study
Doctor M. Mapelli (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Echocardiographic findings in subjects with an amyloidogenic apolipoprotein A1 mutation
Doctor A. Aimo (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Redefining the epidemiology of cardiac amyloidosis. A systematic review of screening studies
Doctor A. Aimo (Pisa, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Highlight on cardiomyopathy
Video

The Event

Event poster

Heart Failure 2022

21 May 2022 16:21 CET
You may be interested in
thumbnail
Congress Session
Improved understanding of the genetic background of cardiomyopathy
thumbnail
Congress Presentation
Rare and common variant drivers of ischemic cardiomyopathy
thumbnail
Congress Presentation
Exome sequencing in over 63,000 patients in TIMI trials uncovers pathogenic cardiomyopathy variant carriers with high risk for heart failure and cardiovascular death

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources